New research suggests it is possible to quickly and accurately diagnose some the most dangerous and drug-resistant types of bacterial infections, using equipment already owned by most hospitals.

Bacteria have been gradually evolving to become resistant to the antibiotics used to treat them. Over the last few years, scientists have found evidence that some bacteria have become resistant to a last-resort antibiotic called colistin.

Now, in a presentation at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), researchers described how they were able to test bacteria to quickly tell whether they were resistant to colistin, and how easily they might pass this resistance on to other bacteria. They say this is an important discovery because knowing which patients have these most dangerous infections means it is possible to use quarantine measures to halt their spread and stop the rise of drug resistance.

The research was presented by Dr Laurent Dortet, Associate Professor at South Paris University, France, and a researcher at Imperial College London, UK. The work was a collaboration between Dr Dortet and colleagues at Imperial, Dr Gerald Larrouy-Maumus and Professor Alain Filloux.

National Diabetes Foot Care Report

National Diabetes Foot Care Report The National...

Trust in health care is essential for dealing with antibiotic resistance

Trust in health care is essential for dealing...

5 key factors expected to bring the total knee replacement market value to $14.9B by 2030

5 key factors expected to bring the total knee...

COVID-19 may promote the spread of drug-resistant ‘superfungus’

Medical News Today recently reported on an...

Antibiotics significantly overprescribed during early months of pandemic, study suggests

According to a study recently shared by Becker’s...

A new bacterial blueprint to aid in the war on antibiotic resistance

ScienceDaily shared a study recently published...

New target for antibiotics promises treatment for multi-drug resistant superbugs

ScienceDaily shared a promising new study from a...

Distribuidor exclusivo.

0